A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.

Autor: S Rebers, E Vermeulen, A P Brandenburg, T J Stoof, B Zupan-Kajcovski, W J W Bos, M J Jonker, C J Bax, W J van Driel, V J Verwaal, M W van den Brekel, J C Grutters, R A Tupker, L Plusjé, R de Bree, J H Schagen van Leeuwen, E G J Vermeulen, R A de Leeuw, R M Brohet, N K Aaronson, F E Van Leeuwen, M K Schmidt

Publikováno v: PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)

BACKGROUND:Despite much debate, there is little evidence on consequences of consent procedures for residual tissue use. Here, we investigated these consequences for the availability of residual tissue for medical research, clinical practice, and pati

Externí odkaz: https://doaj.org/article/4064b89edb524ad9bfc2dc8c7187d3c3

A randomised controlled trial of consent procedures for the use of residual tissues for medical research

Autor: B. Zupan-Kajcovski, J. H. Schagen van Leeuwen, A. P. Brandenburg, W.J. van Driel, R. A. Tupker, Marjanka K. Schmidt, M.W.M. van den Brekel, R. de Bree, Eric Vermeulen, F.E. van Leeuwen, Victor J. Verwaal, T. J. Stoof, L. Plusjé, E. Vermeulen, Marcel C.J. Jonker, Richard M. Brohet, Neil K. Aaronson, Susanne Rebers, Caroline J. Bax, R. A. de Leeuw, Jan C. Grutters, W. J. W. Bos

Publikováno v: PLoS ONE
PLoS ONE [E], 11(3). Public Library of Science
Rebers, S, Vermeulen, E, Brandenburg, A P, Stoof, T J, Zupan-Kajcovski, B, Bos, W J W, Jonker, M, Bax, C J, van Driel, W J, Verwaal, V J, van den Brekel, M W M, Grutters, J C, Tupker, R A, Plusje, L, de Bree, R, van Leeuwen, J H S, Vermeulen, E G J, de Leeuw, R A, Brohet, R, Aaronson, N K, Van Leeuwen, F E & Schmidt, M K 2016, ' A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice ', PLoS ONE, vol. 11, no. 3, e0152509 . https://doi.org/10.1371/journal.pone.0152509
PLoS ONE, 11(3):e0152509. Public Library of Science
PLoS ONE, Vol 11, Iss 3, p e0152509 (2016)

BackgroundDespite much debate, there is little evidence on consequences of consent procedures for residual tissue use. Here, we investigated these consequences for the availability of residual tissue for medical research, clinical practice, and patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb524d66d9c5365604f99c800a7d5a85
http://www.scopus.com/inward/record.url?scp=84962713412&partnerID=8YFLogxK

Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles

Autor: D. P. Bruynzeel, Rik J. Scheper, Thomas Rustemeyer, Susan Gibbs, B.M.E. von Blomberg, H Moed, T. J. Stoof, D. M. Boorsma

Publikováno v: Clinical and Experimental Allergy, 34, 1868-1875. Wiley-Blackwell
Moed, H, Stoof, T J, Boorsma, D M, von Blomberg-van der Flier, B M E, Gibbs, S, Bruynzeel, D P, Scheper, R J & Rustemeyer, T 2004, ' Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles ', Clinical and Experimental Allergy, vol. 34, pp. 1868-1875 . https://doi.org/10.1111/j.1365-2222.2004.02124.x

Background Down-regulation or modulation of T cell activity by immunosuppressive drugs is an effective treatment in diseases where exaggerated T cell responses play a role. A primary effect of the anti-inflammatory drugs (AIDs) is inhibition of the s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0d838f118fdefa2c6bb727fed4029a
https://doi.org/10.1111/j.1365-2222.2004.02124.x

Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells

Autor: Rein Willemze, L. M. H. Van Der Raaij, I. Bruynzeel, T. J. Stoof

Publikováno v: Archives of Dermatological Research. 289:189-193

Pentoxifylline (PTX), a methyl xanthine derivative with phosphodiesterase inhibitory activity, has been shown to have antiinflammatory effects. Previous studies have demonstrated that PTX can suppress TNF alpha production and function, and can inhibi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431c331b1ba9b17fd67e50716484d451
https://doi.org/10.1007/s004030050179

Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy

Autor: H. J. G. Bilo, T. J. Stoof, M.J. Korstanje

Publikováno v: British Journal of Dermatology. 127:501-504

Summary Eight patients with psoriasis received low-dose cyclosporin (CyA) treatment for an average period of 12 months (range 4–16 months). There was great variability in minimal effective CyA dose. In 50% of the patients long-term treatment was li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71fe82f2fd1d02197b8f6d0fc05daab
https://doi.org/10.1111/j.1365-2133.1992.tb14848.x